Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma

@article{Liu2004ExpressionOC,
  title={Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma},
  author={Yulin Liu and Charles D Sturgis and Mark T. Bunker and Reda S. Saad and Ming Y. Tung and Stephen Spencer Raab and Jan F. Silverman},
  journal={Modern Pathology},
  year={2004},
  volume={17},
  pages={1129-1133}
}
Based on clinical and histologic features, differentiating metastatic carcinomas from benign or malignant meningiomas usually is not difficult. Occasionally, however, in some patients without a clinical history of carcinoma, malignant meningiomas can morphologically simulate metastatic carcinoma, necessitating an immunohistochemical study for cytokeratin to make a correct diagnosis. However, the utility of immunohistochemical markers to separate malignant meningioma from metastatic carcinoma… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression. Brain Tumor Pathol 2001;1:1–5

  • M Miettinen, A. Paetau
  • 2001

Similar Papers

Loading similar papers…